Prognostic and predictive value of ER beta 1 and ER beta 2 in the Intergroup Exemestane Study (IES)-first results from PathIES(aEuro)

Author(s):
Speirs, V.; Viale, G.; Mousa, K.; Palmieri, C.; Reed, S.N.; Nicholas, H.; Cheang, M.; Jassem, J.; Lonning, P.E.; Kalaitzaki, E.; Velde, C.J.H. van de (0000-0003-0104-1800); Rasmussen, B.B.; Verhoeven, D.M.; Shaaban, A.M.; Bartlett, J.M.S.; Bliss, J.M.; Coombes, R.C.; PathIES Sub-Comm
Published
2015
Publication type
Article / Letter to editor
breast canceroestrogen receptor betaaromatase inhibitortamoxifenprognosisbiomarker
Date issued
2015-09-30
Language
English
Is part of
Annals of Oncology (2015), Vol. 26, no. 9, p. 1890-1897
hdl
1887/106925
doi
10.1093/annonc/mdv242